Skip to content
FIND A BIOALPS ACTOR

News

If you would like your news to be listed here, please fill in the form to upload your information. Please note, we will only post news related to the life sciences.

Latest BioAlps news

On this page you will find all the latest news regarding BioAlps affiliated members and life sciences activities in western Switzerland.

All the latest press articles featuring BioAlps can be found in our Media Center on our About page.

Debiopharm

BioAlps | 20 years of innovation | Debiopharm

Debiopharm | We develop for patients   We are pleased to share with you our new testimonial series as part…

Ichnos

BioAlps | 20 years of innovation | Ichnos

Developing first-in-class bi-/trispecific antibodies to treat cancer patients   We are pleased to share with you our new testimonial series…

Pharmalp

BioAlps | 20 years of innovation | Pharmalp

Developing and distributing efficacious natural healthcare products   We are pleased to share with you our new testimonial series as…

CSL

BioAlps | 20 years of innovation | CSL Behring

Fast-tracking innovation through long-term mutual partnerships with academia   We are pleased to share with you our new testimonial series…

Vifor Pharma

BioAlps | 20 years of innovation | Vifor Pharma

On a mission to help patients live better, healthier lives   We are pleased to share with you our new…

BioArk

BioAlps | 20 years of innovation | BioArk

Strengthening the Life Sciences value chain from discovery to market   We are pleased to share with you our new…

HES-SO

BioAlps | 20 years of innovation | HES-SO

Supporting the Swiss economy with locally rooted training and applied research   We are pleased to share with you our…

Selexis

BioAlps | 20 years of innovation | Selexis

Selexis | Cell line development meets lab automation and robotics for biologic therapeutic manufacturing   We are pleased to share…

Fongit

BioAlps | 20 years of innovation | Fongit

Fongit | Switzerland’s premier startup incubator   We are pleased to share with you our new testimonial series as part…

SILAB

BioAlps | 20 years of innovation | SILAB

SILAB ǀ Dedicated to promoting a relevant and sustainable innovation in healthcare   We are pleased to share with you…

UNIL

BioAlps | 20 years of innovation | UNIL

UNIL | A commitment to transforming Life Sciences into concrete actions for the benefit of all   We are pleased…

CERN

BioAlps | 20 years of innovation | CERN

CERN | Unique technologies with a wide scope of applications   We are pleased to share with you our new…

Netsensing

BioAlps | 20 years of innovation | Netsensing

Netsensing | Saving lives through the detection of sleep apnea   We are pleased to share with you our new…

JAG

BioAlps | 20 years of innovation | JAG

JAG | Highly automated process plants for the pharmaceutical and biotech industries   We are pleased to share with you…

GGBa

BioAlps | 20 years of innovation | Greater Geneva Bern area

GGBa | The official investment promotion agency for Western Switzerland   We are pleased to share with you our new…

Gnubiotics

BioAlps | 20 years of innovation | Gnubiotics

Gnubiotics | Novel microbiome health solutions   We are pleased to share with you our new testimonial series as part…

GeNeuro

BioAlps | 20 years of innovation | GeNeuro

Fighting against neurodegenerative and autoimmune disease with antibodies   We are pleased to share with you our new testimonial series…

Neurix

BioAlps | 20 years of innovation | Neurix

Minibrain technology enabling efficient drug testing and development   We are pleased to share with you our new testimonial series…

Coat-X

BioAlps | 20 years of innovation | Coat-X

Thin-film encapsulation technology helping increase product reliability and miniaturisation effectiveness   We are pleased to share with you our new…

UCB

BioAlps | 20 years of innovation | UCB

UCB | Creating value for patients now and into the future   We are pleased to share with you our…

Swiss Biotech Association

BioAlps | 20 years of innovation | Swiss Biotech Association

SBA | Representing the interests of the Swiss biotech industry   We are pleased to share with you our new…

Socorex

BioAlps | 20 years of innovation | Socorex

60 years of high-quality manufacturing of liquid handling instruments   We are pleased to share with you our new testimonial…

Debiotech

BioAlps | 20 years of innovation | Debiotech

Key medtech player fostering innovative medical software solutions and device development projects   We are pleased to share with you…

Biopôle

BioAlps | 20 years of innovation | Biopôle

High-quality support and valuable community for life sciences companies   We are pleased to share with you our new testimonial…

KATZAROV

BioAlps | 20 years of innovation | KATZAROV

Intellectual property for Life Sciences innovators   We are pleased to share with you our new testimonial series as part…

Incyte Bioplant

New Incyte bioplant opens in Switzerland

Incyte opens its new bioplant in Yverdon-les-bains in the Canton of Vaud   On 31 August 2021, Incyte, the US-based…

CSEM

BioAlps | 20 years of innovation | CSEM

Supporting the Life Sciences industry with cell-tech, biomonitoring and lab automation know-how   We are pleased to share with you…

iOnctura

BioAlps | 20 years of innovation | iOnctura

iOnctura | Better drugs to beat cancer resistance   We are pleased to share with you our new testimonial series…

Combioxin SA

Combioxin signs a worldwide licensing agreement

Combioxin has signed a worldwide licensing agreement with Eagle Pharmaceuticals Eagle Pharmaceuticals has entered into a worldwide licensing agreement with…

AC Immune

BioAlps | 20 years of innovation | AC Immune

Addressing the slow pandemic of neurodegenerative diseases   We are pleased to share with you our new testimonial series as…

Innovaud

BioAlps | 20 years of innovation | Innovaud

Connecting tech-oriented companies | Supporting cross-cutting innovation   We are pleased to share with you our new testimonial series as…

Geneus

BioAlps | 20 years of innovation | Geneus

Life Sciences innovation initiator | Transforming ideas & research into startups   We are pleased to share with you our…

SIB Swiss Institute of Bioinformatics

BioAlps | 20 years of innovation | SIB Swiss Institute of Bioinformatics

SIB | Supporting the Life Sciences community with Computational Biology and Bioinformatics know-how   We are pleased to share with…

Abionic

BioAlps | 20 years of innovation | Abionic

Nanotechnology to detect sepsis in 5 minutes from one drop of blood   We are pleased to share with you…

HEPIA Tissue Engineering Lab

BioAlps | 20 years of innovation | HEPIA Tissue Engineering Lab

Microtech tools meet novel integrated in vitro cellular model to help accelerate research    We are pleased to share with…

Lunaphore

Lunaphore | Top 10 Spatial Biology Companies

Lunaphore was selected as one of the top 10 spatial biology companies in the world   Lunaphore Technologies has been…

Fongit

FONGIT Innovation Fund selects four startups

FIF | FONGIT Innovation Fund Following the announcement of the creation of the FONGIT Innovation Fund (FIF), the foundation supporting…

Distalmotion

Distalmotion | Pioneering Hybrid Robotics in General Surgery

CHUV performed the world’s first hybrid robotic general surgery   Distalmotion & CHUV announced the successful start to a case series…

EBAMed

EBAMed | Prospective Imaging Study

First patient enrollment   EBAMed announced first patient enrolled in prospective imaging study with ultrasound guidance prototype in ventricular tachycardia…

SOPHiA GENETICS | Opts for Nasdaq IPO

Closing of $234 mio. Initial Public Offering & $20 mio. Private Placement   SOPHiA GENETICS SA (Nasdaq: SOPH), the creator…

Oncology

CHUV | A breakthrough in oncology

CHUV | Biomarkers which could save lives   Scientists at CHUV have identified cells which create metastasis in a tumour….

Merck

Merck | New Biotech Development Center

Merck reaches key milestone in the construction of its Biotech Development Center Announced in January 2020, Merck‘s new state-of-the-art biotech development…

Asceneuron

Asceneuron | Appoints new Board Member

Underscores company’s ambition to deliver on the unmet needs of patients living with neurodegenerative diseases

Drug Discovery World

Drug Discovery World | Switzerland as a global biotech hub

Why Switzerland continues to punch above its weight as global biotech hub | Drug Discovery World To understand Switzerland’s continued…

AC Biosciences

AC BioScience | Committed to fight against cancer

Interview with Andreas Schläpfer, CEO & cofounder   AC BioScience, the Vaud based company is a pioneer in the development…

EPFL

EPFL | A virus to identify small peptide mimics of antifreeze proteins

Scientists at EPFL (Polymers Laboratory) and the University of Warwick have used a virus to identify a peptide that can…

EPFL

EPFL | Next-generation implants will be biodegradable and non-invasive

Tissue grows back once the implant is gone   EPFL engineers have developed a neural interface that disappears harmlessly in…

CSEM

CSEM | Solid 2020 results despite the tough economic climate

Digital support to Gait Up    CSEM posted a solid financial performance in 2020 and made further progress on important technological…

Swiss Diabetes Venture Fund

Swiss Diabetes Venture Fund | 1st venture fund dedicated to diabetes technology

CHF 50 million for diabetes ventures Launch of the first venture fund dedicated to diabetes technology, through a collaboration between…

UNIGE

UNIGE | How do immune cells get activated?

Decoding the activation mechanism of the CCR5 receptor By studying the structure of cellular receptors and of the molecules that…

EPFL

EPFL | Tailored optical stimulation for the blind

Stimulation of the nervous system with neurotechnology EPFL scientists in a European collaboration propose a personalised protocol for optimising stimulation…

CERN

CERN | CLEAR study paves the way for novel electron-based cancer therapy

High-energy electron beams can be focused onto deep-seated cancerous tumours   The study, conducted at CERN’s CLEAR test facility, demonstrates…

PharmaPlan

Pharmaplan (TTP Group) | New office in Visp close to Lonza

New office with 60 employees   In response to the investment boom in the pharmaceutical industry, Pharmaplan is opening another…

LABIOTECH.EU

Top 15 Swiss biotech startups making a difference in Europe

This article was written by Labiotech.eu with the support of BioAlps, the Greater Zurich Area, and Switzerland Global Enterprise (S-GE)….

Fondation Leenaards

Leenaards Foundation | Science Prize 2021

CHF 1.4 mio for biomedical research in the Lake Geneva region   The Leenaards Foundation has awarded Science Prizes to…

HEIG VD

HEIG VD | Rethinking the manufacture of cell & gene therapies

  HEIG-VD is joining forces with the EPFL and the University of Geneva (UNIGE) to take up the challenge of…

Embion

Embion | Nominated for the Swiss Economic Award 2021

The most important prize for young entrepreneurs in Switzerland   From dozens of applications, nine companies were nominated for the…

FONGIT

FONGIT Innovation Fund (FIF)

The first two beneficiaries of the FIF   The foundation supporting technological entrepreneurship in the canton of Geneva, FONGIT, announces…

EPFL

EPFL | How healthy is your digital twin?

Ethical & legal questions   Digital twins – a savvy combination of artificial intelligence and personal data – have already…

Venturelab

Venturelab | Venture Leaders Medtech 2021

Meet the Swiss national MedTech team   The Swiss National Startup Team has 10 new members: 10 startups were selected…

Abologix

Abologix | Wins CHF 150,000

Sum used to develop targeted antibodies for cancer patients   Abologix develops a new therapeutic option to treat lymphoma patients…

Rheon Medical

Rheon Medical | 1st implantation of the “Eyewatch” implant in Valais

The eyeWatch system is the world’s first adjustable system for treating glaucoma   The first patient in Valais has benefited…

UNIGE

UNIGE | Replicating patients’ tumours to test different treatments

The critical role of the immune system in the fight against cancer   UNIGE Researchers have developed in vitro tumour…

SIB Swiss Bioinformatics Institute

SIB | A year of Swiss data science for life: activity report 2020

Welcome to new activity report of the SIB Swiss Institute of Bioinformatics, the nationwide organisation dedicated to biological and biomedical…

GGBa

GGBa | Geneva welcomes new global health investment advisory

Geneva as a center for global public health development   Initially launched in the United States, Baraka relocated to Geneva…

EarlySight

EarlySight | Seed round closing

1st closing round of CHF 2.3 million   EarlySight is delighted to announce the first closing of CHF 2.3 million…

Selexis

Selexis | “Best Workplaces™ Switzerland” 2021

One of the Best Workplaces™ Switzerland for fourth straight year   Selexis SA, a JSR Life Sciences company, announced that…

Heidi.news

Heidi.news | The Swiss Confederation reinvests in the development of Swiss vaccines

A CHF 50 million incentive programme   The Swiss Confederation hopes to contribute to making Switzerland a place of research…

Switzerland Global Enterprise

S-GE | The new EU Medical Device Regulation (MDR) came into force on 26 May 2021

Medical devices regulation (MDR): overview   What do exporters need to know about the Medical Devices Regulation (MDR)? The date…

Haya Therapeutics

Haya Therapeutics | Completes CHF 18 mio. seed financing

Anti-fibrotic therapies targeting long non-coding RNAs   HAYA Therapeutics, SA, a company developing precision medicines that target tissue and cell-specific…

CERN

CERN | Innovate in healthcare with CERN

Connecting Life Sciences Innovators (CLSI) event On 18 March, 2021 the Medical Applications section of the CERN Knowledge Transfer (KT)…

Biopôle

Biopôle | New start-up fund to foster early innovation in the Life Sciences

Accelerate the innovation of start-ups established at Biopôle    Biopôle SA, a privately held Swiss not-for-profit organisation that manages and promotes…

EPFL

EPFL | Cancer cells hijack the 3D structure of DNA

A novel algorithmic approach on cancer cells   Scientists at EPFL and UNIL have used a novel algorithmic approach on…

bNovate

bNovate | Fundraising to expand commercial activities internationally

CHF 5 million fundraising bNovate Technologies SA, a Swiss company specialised in industrial microbiology aiming at increasing the safety of…

Flowbone

Flowbone | Winner of the 2nd round of the Venture Kick competition

Prize of CHF 50’000   EPFL scientists have developed a gel that can locally reinforce bones weakened by osteoporosis. The scientists…

Lonza

Lonza | Invests CHF 650 million in Visp

Significant investments to expand its mammalian drug substance manufacturing facilities in Visp The Lonza‘s expansion in Visp (Valais, Switzerland) will…

Swiss Biotech Center

Swiss Biotech Center | Covid-19: a 2nd generation vaccine in preparation in Monthey

Strategic collaboration agreement between Swiss Biotech Center & Berna Biotech Pharma The Swiss biotech companies Berna Biotech Pharma Gmbh and…

Alithea Genomics

Alithea Genomics | Has been awarded CHF 150,000

CHF 150,000 for RNA sequencing to boost biomedical research Lausanne-based Alithea Genomics, developing a novel technology that enables a high…

Debiopharm

Debiopharm | Launch of the “Innovation DEbiopharm Academia Léman” (IDEAL)

The Lemanic region as a hub for Life Science innovation   Debiopharm a Swiss biopharmaceutical company based in Lausanne, announced the…

Calciscon

Calciscon | Raised CHF 2.5M Series A

Commercialisation of the T50 Test to drive more efficient therapies for renal patients    Calciscon AG announced  the closing for…

Gondola Medical Technologies

Gondola Medical Technologies | New research momentum

Building clinical research momentum with 500’000 CHF Tech Growth loan Clinical research and studies demonstrate Gondola Medical Technologies AMPS therapy’s…

EPFL

EPFL | New “brain stress test” for evaluating the mental status of patients with Parkinson’s disease

Awakening “ghosts” in patients with Parkinson’s   EPFL scientists are developing a completely new “brain stress test” for evaluating the…

HCK

Healthcare Konnect (HCK) | Distribution agreement signed with VUNO

Introduction of AI suite in Swiss medical institutions   South Korean Medical AI trailblazer, VUNO, and Swiss medical distribution company,…

Biopôle

Biopôle | Neurotechnologies offer new hope for patients with Parkinson’s disease

3 Biopôle-based companies are striving to find innovation solutions   CHUV-NeuroTech, ND BioSciences & Gondola Medical Technologies , 3 Biopôle-based companies are…

Mybiopassport

CoreMedica Europe | Intercantonal collaboration on SARS-COV-2 detection in saliva 

Partnership on the analysis of SARS-COV-2 virus in saliva using the RT-PCR method   CoreMedica Europe a Swiss biotechnology company based…

HEIG VD

HEIG – VD | Innovations in health care

A brand new tool is available to map the organisational impacts    Innovation in health care is shaking up and…

ADC Therapeutics

ADC Therapeutics | FDA Approval of ZYNLONTA™

FDA Approval of ZYNLONTA™ in Relapsed or Refractory Diffuse Large B-Cell Lymphoma   ADC Therapeutics SA announced that the Food…

Swiss Biotech Association

Swiss Biotech Association | Record year for Western Switzerland’s biotech industry

An attractive, dynamic & ever-growing life sciences ecosystem   Biotechnology companies based in Switzerland have experienced record investments in the…

EPFL

EPFL | New hydrogel can repair tears in human tissue

An injectable gel that can attach to various kinds of soft internal tissues    EPFL scientists have developed an injectable…

Ferring

Ferring Pharmaceuticals | Ferring Biologics Innovation Centre opens at Biopôle

A new hub for biologics R&D in Western Switzerland   On 1 April 2021, the research-driven biopharmaceutical group Ferring Pharmaceuticals…

GGBa

GGBa | 85 new foreign companies in Western Switzerland in 2020

In 2020, 85 new foreign companies set up shop in Western Switzerland, supported by Greater Geneva Bern area (GGBa) and the…

Lonza

Lonza | Hiring of 1200 people in Visp

Lonza, the Valais-based company, is hiring of 1200 people for its plant in Visp (Valais, Switzerland), 650 have already been…

Swiss Institute of Bioinformatics (SIB)

SIB | Discover the SIB Remarkable Outputs 2020

Discover 10 Remarkable Outputs of 2020, brought to you by scientists from the SIB Swiss Institute of Bioinformatics, across Switzerland.

CSEM

CSEM | 2020 Digital Journey Award

Gait Up & Definition12 win the 2020 CSEM digital journey award   CSEM has announced the two winners of its…

SIB Swiss Bioinformatics Institute

SIB | Creation of a Swiss SARS-CoV-2 Data Hub 

Accelerating global COVID-19 research with a Swiss SARS-CoV-2 Data Hub  Over the past weeks and with the threat of emerging…

Inait

Inait | Joined the Scale Up Vaud program

Artificial Brain Intelligence (ABI)   An annual label created in 2016, Scale Up Vaud helps the CEOs of high-growth Vaud…

Netsensing Technology

Netsensing Technology | SmartEEs2 (EU H2020) contracting phase

The EU consortium will reinforce its penetration to global market & its position with EU partners   Incubated at Microcity,…

Terapet

Terapet | Proton therapy

CHF 1.5M of non-dilutive funding   Terapet SA, a privately held Swiss MedTech company developing innovative solutions for a safer,…

Adiposs

Adiposs | Green light for clinical trials

ImageBAT   Following the scientific advice meeting with The Medicines and Healthcare products Regulatory Agency in the UK,  the Geneva…

CHUV HUG EPFL

CHUV, EPFL, HUG | AI now sees & hears COVID in your lungs

Deep learning algorithms automating the prediction of diagnosis & outcome of Covid-19 from chest images and breath sounds   DeepChest…

Asceneuron

Asceneuron SA | Awarded by the Alzheimer’s Drug Discovery Foundation

Asceneuron Receives USD 2.2 Million Award from the Alzheimer’s Drug Discovery Foundation. Award will fund first in human clinical trials of next generation O-GlcNAcase inhibitor, ASN51, to start Q2 2021

EPFL Innovation Park

EPFL Innovation Park |  First Femtech accelerator in Switzerland (Tech4Eva)

In honor of Women’s International Day, EPFL Innovation Park is announcing the launch of Tech4Eva, the first Femtech accelerator in Switzerland,…

Biopôle

Biopôle | Hosts the 1st branch of Superlab Suisse

The centre will open by the end of the 2nd quarter of 2021   Superlab Suisse AG, a Zurich-based private…

EBAMed

EBAMed | Swiss-based medtech startup

New CEO   EBAMed SA, developer of medical technologies to transform the treatment of cardiac arrhythmias, has appointed experienced specialist…

Biopôle

Biopôle | 3 new buildings by 2024

Life Sciences cluster   The Biopôle site continues its strong development with the construction of three new buildings. By 2024,…

Canton Neuchâtel

New training course: chemical & pharmaceutical production technologist

Close collaboration between biopharmaceutical companies & Canton de Neuchâtel   The Canton of Neuchâtel will open up a new dual-mode training route…

Universität Bern

Bern Center for Artificial Intelligence in Medicine (CAIM)

A new platform in the field of Artificial Intelligence in medicine   The University of Bern & the Inselspital, Bern…

Universität Bern

Multidisciplinary Center for Infectious Diseases & Immunity (MCIDI)

Newly founded: MCIDI   The University of Bern established a multidisciplinary center to study the origin and course of infectious…

Zeta

ZETA | A new subsidiary in Switzerland (Visp, VS)

Switzerland is the Mecca of the pharmaceutical industry   ZETA, the engineering specialist for the pharmaceutical and biotech industries, manages…

Distalmotion

Distalmotion | Received European CE mark for Dexter surgical robot

Dexter surgical robot  Distalmotion, a Swiss-based medical device company establishing a new global standard of care ensuring every patient can…

Debiopharm

Debiopharm | Phase II research against covid-19 launched

Antiviral Alisporivir: a valuable additional therapy to SOC   Debiopharm, a Swiss biopharmaceutical company, announced the first patient dosed in…

ADR-AC | A new testing service against the new Coronavirus 2019

ADR-AC GmbH, Bern launches a laboratory analysis test service for memory T cells against the novel 2019 Coronavirus

Swiss Medtech

Swiss Medtech | Award 2021

Call for entries 2021 marks the 4th year that the Swiss Medtech Award recognises outstanding achievements in the Swiss medical…

EPFL

EPFL | New synthetic molecule to kill the flu virus

EPFL scientists have developed a synthetic molecule capable of killing the virus that causes influenza. They hope their discovery will…

EspeRare Pierre Fabre

EspeRare & Pierre Fabre | A pioneering treatment for XLHED

Co-develop the ER-004 treatment   The EspeRare Foundation and Pierre Fabre join forces to develop and market a pioneering treatment…

Comphya

Comphya | Raised additional USD 1.3 million

Additional USD 1.3 million to secure the execution of the pilot clinical trials to start early 2021   One year…

ABCDx

ABCDx | Submit StrokeCheck for clearance in the US & EU

Targeting launches in the US & EU: 2021   Swiss diagnostics firm ABCDx is developing a point-of-care blood test for…

Lymphatica

Lymphatica Medtech | Raises seven-digit Series A round

LymphoDRAIN product: advance in clinical trials & improve the usability and digitisation   LYMPHATICA Medtech, a vascular medical device development…

SICHH

SICHH | BrainFit4Life project

The new SICHH symposium series is supported by Innosuisse    The Swiss Integrative Center for Human Health (SICHH) is supported…

Biopôle CSL Behring

CSL BEHRING REI & BIOPÔLE | A new collaboration partnership

New opportunities in R&D and technology development   The CSL Behring Research External Innovation (REI) team in Europe & Biopôle…

Abionic

Abionic | Five-minutes test for scoring COVID-19 severity

The 1st COVID-19 severity score facilitating patient triage   Abionic launched a 5-minutes test for scoring COVID-19 severity. This test…

HESAV Campus Santé

HESAV | A new Campus dedicated to Health

A Campus for new synergies   Consisting of three main buildings, the campus will be a training centre for health…

SEED Biosciences

SEED Biosciences | Completes CHF 1 mio. series A financing round

New private investor   Life-sciences startup SEED Biosciences raised CHF 1 million in a Series A fundraising round. The capital…

Eyeware

Startup Eyeware | Products available all the way to Japan!

Eyeware has just entered into a partnership with the company Studio Uni    The startup Eyeware, hosted at IdeArk in…

Netsensing Technology

Netsensing Technology | Raised funds for it Home Sleep Apnea Test (HSAT)

Netsensing Technology secures a seed financing round to accelerate Home Sleep Apnea Test device development   Netsensing Technology Sàrl has…

COVID-19

SICHH | “Connect People with Science” platform

A new scientific communication platform   A new scientific communication platform entitled “Connect People with Science” is being launched. Its…

JSR Life Sciences

JSR | Expands its European Gene-to-GMP in Geneva

Geneva: 250 new highly technical jobs   JSR Life Sciences, LLC announced that it is increasing its European footprint with…

Plair SA MBV

Plair SA – MBV | Signature of a collaboration agreement

Signature of a collaboration agreement to develop next-generation solutions for rapid microbiological detection Plair SA, the Swiss creator, manufacturer, and…

EPFL

COVID-19 Testimonial Series | Laboratory of Biological Network Characterization (LBNC)

Next generation microfluidic devices for applications in molecular diagnostics   The following article is part of BioAlps’ testimonial series and…

Technology by Bilan 2020

Technology by Bilan 2020

Revolution in Healthcare | How robotics, virtual reality and artificial intelligence are improving the profession   Bilan, in partnership with…

EPFL

COVID-19 Testimonial Series | EPFL’s Laboratory of Microbiology and Microtechnology

Cutting-edge microfluidics to study the behaviour of bacterial pathogens under fluctuating environments   The following article is part of BioAlps’…

CSL Behring

CSL Behring | Opening of a new manufacturing facility in Bern (Switzerland)

To meet the high demands for immunoglobulin products, CSL Behring is expanding its manufacturing capacities in Bern   The new…

MaxiVAX

COVID-19 Testimonial Series | MaxiVAX

The Geneva-based immune-oncology startup contributing to the SARS-CoV-2 vaccine development   The following article is part of BioAlps’ testimonial series…

Sophia Genetics

SOPHiA GENETICS raises $110 million in oversubscribed new funding round

Supporting the Company’s Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine   SOPHiA GENETICS, global leader…

GaDia

COVID-19 Testimonial Series | GaDia

A rapid diagnostic test for the detection of antibodies against COVID-19   The following article is part of BioAlps’ testimonial…

Coronasense

COVID-19 Testimonial Series | Coronasense

A device capable of autonomously screening the body temperature to detect fever symptoms caused by viral or bacterial infections  …

CERN

COVID-19 Testimonial Series | CERN

Leveraging CERN’s novel technologies and know-how to develop health applications   The following article is part of BioAlps’ testimonial series…

SwissCovid

COVID-19 Testimonial Series | SwissCovid

SwissCovid app | Privacy by design   The following article is part of BioAlps’ testimonial series and was written by…

Takeda

COVID-19 Testimonial Series | Takeda Neuchâtel Manufacturing Site

Reorganisation of teams and work streams to ensure the production and delivery of life-saving products while protecting the health of…

HUG

COVID-19 Testimonial Series | HUG Innovation Center

Digital solutions, fundamental and clinical research, and organisational process redesign to support the fight against COVID and enhance the physicians-patients…

JAG

COVID-19 Testimonial Series | JAG Process Solutions

Development of vaccine, drugs and robotic disinfection equipment to fight COVID-19   The following article is part of BioAlps’ testimonial…

EBAMed

EBAMed annonces EUR 2.4 million grant

EBAMed receives a EUR 2.4 million grant from the EU Horizon 2020 Research and Innovation Program   EBAMed is glad…

SwissKH

COVID-19 Testimonial Series | SwissKH

Swiss-made protective visor and door opening device to protect against COVID-19   The following article is part of BioAlps’ testimonial…

Vaccine Formulation Institute (VFI)

COVID-19 Testimonial Series | Vaccine Formulation Institute (VFI)

Open-access adjuvants and vaccine formulation expertise to benefit the whole community in the fight against COVID-19   The following article…

Aquanetto

COVID-19 Testimonial Series | AquaNetto

Fluid and surface disinfection sustainable modular solutions to fight against COVID-19   The following article is part of BioAlps’ testimonial…

UCB

COVID-19 Testimonial Series | UCB

Supporting patients, healthcare providers and communities worldwide through treatment and vaccine research, testing resources and donations   The following article…

Neurix

COVID-19 Testimonial Series | Neurix SA

A Swiss in vitro drug testing platform for the identification of potential treatments against coronavirus   The following article is…

UNIGE Biopharmaceutics

COVID-19 Testimonial Series | UNIGE Biopharmaceutics

Development of mRNA and DNA vaccines against COVID-19   The following article is part of BioAlps’ testimonial series and was…

Spentys

COVID-19 Testimonial Series | Spentys

High-quality 3D scanning, modelling, and printing solutions for healthcare providers   The following article is part of BioAlps’ testimonial series…

Norgren

COVID-19 Testimonial Series | Norgren (FAS)

Swiss manufacturer of liquid valves, syringe pumps and mass flow controllers supporting the high-level of demand in ventilators   The…

Combioxin SA

COVID-19 Testimonial Series | Combioxin SA

First-in-class life-saving drugs for severe infections   The following article is part of BioAlps’ testimonial series and was written by…

Helvetica Health Care

COVID-19 Testimonial Series | Helvetica Health Care

Marketing and distribution of a wide range of molecular controls and panels   The following article is part of BioAlps’…

PICC Solution

COVID-19 Testimonial Series | PICC Solution

How AI can support research by extracting, analysing and compiling data The following article is part of BioAlps’ testimonial series…

Embedded Systems Laboratory

COVID-19 Testimonial Series | Coughvid

How AI applied to cough recordings can help in the identification of COVID-19 cases   The following article is part…

Distillery Morand

COVID-19 Testimonial Series | Morand Distillery

From spirit production to hand sanitisers   The following article is part of BioAlps’ testimonial series and was written by…

SICHH

COVID-19 Testimonial Series | Swiss Integrative Center for Human Health (SICHH)

Adapting to become a satellite laboratory to carry out genetic testing of SARS-Cov-2 for the Fribourg Hospital (HFR)   The…

Daphne Technology

COVID-19 Testimonial Series | Daphne Technology

From exhaust gas cleaning system to easy-to-assemble face shield against COVID-19   The following article is part of BioAlps’ testimonial…

E4S

COVID-19 Testimonial Series | E4S

E4S’ Testimonial | A policy approach to fighting COVID-19   The following article is part of BioAlps’ testimonial series and…

Abionic

COVID-19 Testimonial Series | Abionic

A rapid sepsis test, the key to saving lives   The following article is part of BioAlps’ testimonial series and…

MedCo

COVID-19 Testimonial Series | MedCo

Secure, privacy-conscious data analytics among hospitals   The following article is part of BioAlps’ testimonial series and was written by…

Netsensing

COVID-19 Testimonial Series | Netsensing

Patients with sleep apnea are more at risk when infected with COVID-19   The following article is part of BioAlps’…

SIB Swiss Bioinformatics Institute

COVID-19 Testimonial Series | SIB Swiss Bioinformatics Institute

Bioinformatics, a crucial key to a rapid response to the COVID-19 threat   The following article is part of BioAlps’…

CSL Behring

COVID-19 Testimonial Series | CSL Behring

In-house expertise, strategic partnerships and collaboration   The following article is part of BioAlps’ testimonial series and was written by…

SOPHiA GENETICS and Dasa join forces to fight cancer

SOPHiA GENETICS and Dasa foster a new data-driven medicine era in the fight against cancer   On 23 July, SOPHiA…

Eye imagery

Eye imagery revolutionised

New MRI method, developed in Lausanne enhances eye imagery and clears new path for further research   Research from the…

Incyte inauguration 2020

Incyte gets installed in the canton of Vaud

Incyte inaugurates its new European HQ in Morges   In July 2020, the global pharmaceutical company, Incyte inaugurated its new…

Medtech

Artiria Medical raise CHF 3 million in series A

Artiria Medical raises CHF 3 million to improve stroke treatment   EPFL spin-off, Artiria Medical, is developing micro-actuated catheters and…

iOnctura

iOnctura raise €20 million for series A

iOnctura raise an additional €5.1 million for their series A funding, reaching a total of €20.1 million   The Geneva-based…

EMBION

EMBION™ Technologies develops a new solution

EMBION™ Technologies S.A., hard-tech, disruptive innovator in plant-based bioactives for the nutrition of the future, announces the market launch of PREMBION™. It is the first patented product with complex prebiotic properties for animal nutrition that was created with EMBION’s novel platform technology. The spin-off of the Swiss Federal Institute of Technology in Lausanne (EPFL) accelerates nutrition innovation toward increased functionality and greater affordability. It reduces the time from discovery to commercial production by up to 80%. Market introduction tests are currently underway with leading global corporations in the food, feed and drinks sectors.

CoreMedica Europe

CoreMedica Europe | Enters the COVID-19 blood test race

CoreMedica Europe | A blood test to screen your immune system   The Geneva-based startup has entered the COVID-19 diagnostics…

Polares Medical

Polares Medical raises $40M

Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies   On 25 June 2020, Polares Medical SA, a…

University of Bern

University of Bern Institute of Infectious Diseases (IFIK) opens a new laboratory

Unique biosafety laboratory at the University of Bern   On 16 June, the new BSL-3 biosafety laboratory of the University…

CoreMedica Laboratories

CoreMedica Laboratories Inc. implements Roche Elecsys antibody test for COVID-19

CoreMedica Laboratories Inc. provides COVID-19 serology confirmations via a secondary antibody detection method   On 12 June 2020, CoreMedica Laboratories,…

HMCare

HMCare to develop a transparent surgical mask

HMCare will launch the production of its HelloMask as of early 2021   For the past two years, the EPFL…

GliaPharm

GliaPharm raises CHF 1.5 million

GliaPharm reaches a total of CHF 2 million raised to further its drug development   On 25 May 2020, EPFL…

Bachem

Bachem supports the fight against COVID-19 worldwide

Bachem supplies key anaesthetic drug to support fight against COVID-19   The Swiss-based company, Bachem, is the world leader in…

BioAlps Networking Day 2020

Save the Date | BioAlps Networking Day

BioAlps Networking Day 2020 | Annual gathering of Western Switzerland’s Life Sciences’ Community   The event is planned to take…

Abionic

COVID-19 | Abionic’s solution, a life saver

Abionic’s sepsis test supports the fight against COVID-19   When the pandemic hit, Abionic was finalising a financing round to…

Lonza

Lonza & Moderna partner to produce COVID-19 vaccine

Lonza | A key player in the COVID-19 vaccine production   Lonza, the Valais-based company, has signed a 10 year…

SILAB

Partnership offer for SNF NRP78 “Covid-19” call

SNF NRP78 « Covid-19 » Call | Collaboration opportunity with SILAB   SILAB can be a real asset to develop…

ADC Therapeutics

ADC Therapeutics goes public

ADC Therapeutics chooses the New York Stock Exchange   On 15 May 2020, the Biopôle-based company, ADC Therapeutics went public….

AquaNetto | Extended use of the same mask

AquaNetto enables you to wear the same mask for an extended period of time   Based in the canton of…

COVID-19

Incyte & Novartis enter phase II trials with Jakafi drug

Partners are taking Jakafi drug into a second late-stage trial for COVID-19 patients on ventilators   On 5 May 2020,…

COVID-19

COVID-19 | AIDES POUR LES START-UP

In light of the COVID-19 situation, we are exceptionally posting information in French on our website. Do not hesitate to…

HUG Clinical Trial

COVID-19 | HUG launch a clinical trial

HUG | Preventive treatment for people in contact with COVID-19 patients   The HUG launch a clinical trial called CoPEP…

Medtronic

Medtronic shares ventilator specifications

Medtronic is publicly sharing design specifications for its ventilators to support the fight against COVID-19   Medtronic is sharing the…

COVID-19

A simultaneous diagnostic test for COVID-19, flu and SRAS infections

Adamant Innotech and CSEM develop a simultaneous diagnostic test for past COVID-19, flu and SRAS infections   On 9 April…

Quotient Limited

Quotient Limited | SARS-CoV-2 Antibody Test

Quotient Limited Announces the Completion of the SARS-CoV-2 Antibody Test Development   Vaud-based Quotient Limited announced on 6 April 20202,…

Augurix GaDia

Augurix and GaDia develop a rapid COVID-19 serological test

First rapid COVID-19 serological test to enter Swiss market   On 6 April 2020, Augurix SA and GaDia announce the…

Gnubiotics

Gnubiotics joins the fight against COVID-19

Gnubiotics accelerates testing of multivalent-glycan based pipeline candidates against viral entry of COVID-19   Since 2016, Gnubiotics has invested in…

COVID-19

COVID-19 | MESURES ECONOMIQUES

In light of the COVID-19 situation, we are exceptionally posting the information in French on our website. Do not hesitate…

Aktiia

Aktiia raises CHF 6 million

Aktiia raises new funds to finalise last steps towards market entry   Neuchâtel-based Aktiia, created in 2018, has developed a…

Medtech

New EU Medical Devices Regulation to be delayed by a year

European Commission seeks to delay the new EU Medical Devices Regulation (MDR)   Stella Kyriakides, the European Commissioner for Health…

Swiss Medtech

Information from Swiss Medtech

Swiss Medtech companies defined as part of Switzerland’s critical infrastructure   The Federal Department of Defence, Civil Protection and Sport…

Rheon Medical

Rheon Medical acquires the CE Marking

Rheon Medical to launch its eyeWatch product on the Swiss and EU markets   The Vaud-based startup, Rheon Medical, specialised…

1Drop

1Drop Diagnostics to board the International Space Station

1Drop brings medical diagnostics to space   The Neuchâtel-based company, 1Drop Diagnostics, which specialises in the detection of cardiovascular biomarkers…

Neuro

UNIFR & SICHH | New Alzheimer’s diagnosis

Teams from UNIFR & SICHH discover a new Alzheimer diagnosis solution based on saliva analysis   The University of Fribourg…

Abionic

Abionic’s sepsis test | A diagnosis solution for the new Coronavirus

Abionic’s R&D focuses on the development of an early sepsis diagnosis solution | A tool for Coronavirus identification   Abionic,…

EBAMed joins the Mayo Clinic Business Accelerator

EBAMed joins the Mayo Clinic Business Accelerator and starts pre-clinical testing   EBAMed SA, a medical technology company enabling access…

Cordsavings

Cordsavings | A Decisive Alliance in Stem Cell Biobanking

Los Angeles – Geneva – Monthey: CSG-BIO SA (CSG-Bio), which intends to offer the most advanced and comprehensive stem cell banking services to families worldwide in the near future, took over some of CryoSave AG’s assets in 2019. It has now announced the signing of an agreement with CORDSAVINGS SA (CordSavings), the reputed independent Swiss neonatal stem cells laboratory, to secure the hundreds of thousands of stem cell samples left in insecurity following the bankruptcy of the Swiss company Cryo-Save AG in September 2019.

SOPHiA GENETICS

SOPHiA GENETICS Appoints Chief Medical Officer

New appointment at SOPHiA GENETICS to accelerate the execution of its Medical Strategy   On 13 February 2020, SOPHiA GENETICS, leader…

Lunaphore

Lunaphore raises CHF 23 million

Lunaphore closes its Series C funding   On 6 February 2020, the EPFL spin-off, Lunaphore, founded in 2014, announced the…

New GE Healthcare manufacturing site in western Switzerland

New centre of excellence in the canton of Vaud | GE Healthcare Life Sciences   GE Healthcare Life Sciences will…

CSEM

ORGANTRANS | A milestone in regenerative medicine

Creation of a European Consortium | ORGANTRANS   On 4 February 2020, the CSEM announced the creation of  the European project ORGANTRANS….

Swiss Venture Capital Report 2020

Swiss Venture Capital Report 2020

The Swiss Venture Capital Report 2020 is out | Encouraging results for biotech and healthcare IT sectors   The 8th…

Novostia

Novostia receives grant from the European Commission

European Innovation Council (EIC) Accelerator | Novostia part of the 9 selected Swiss startups   The European Commission selected 75 startups…

GeNeuro

GeNeuro closes €17.5 million private placement

GeNeuro secures investment to further clinical trials   GeNeuro, the Geneva-based biopharmaceutical company, announced on 31 January 2020 the securing…

Endotelix Diagnostics

Endotelix Diagnostics wins VentureKick Stage 3

Endotelix Diagnostics Sàrl | Solution provider for Antiphospholipid Syndrome   In 2020, VentureKick allocated CHF 5 million to 80 Swiss startup projects.  …

Merck

Merck invests €250 million in Switzerland

Merck Biotech Development Center | New Facility in Switzerland   On 27 January 2020, Merck announced a €250 million investment…

Nanolive

Nanolive is moving to a new office location

Another milestone for Nanolive, as the company moves to new offices   In 2013, Nanolive started its adventure in a…

Abionic

Abionic | Hitting the European and US markets

Abionic to commercialise its rapid sepsis diagnosis product on the EU and US markets   The Abionic team, who has…

SILAB

NTN Innovation Booster | Contribute to the Future of Healthcare with SILAB

Join SILAB and take part in Innosuisse’s NTN Innovation Booster programme Imagine and develop the healthcare of tomorrow   Innovation…

qmt

Qualimatest & SAPHIR join forces to become qmt

qmt | The industry’s quality test and control reference   On 9 January 2020, SAPHIR and Qualimatest announced that their…

Healthcare Konnect

Oxipit partners with HealthCare Konnect | Press Release

Medical imaging technology company Oxipit announced partnership with Swiss medical distribution company Healthcare Konnect to bring ChestEye AI imaging suite to healthcare institutions in Nigeria. The partnership aims to introduce vanguard AI diagnostic capabilities and improve detection of 75 pathologies, including tuberculosis, to one of the largest markets in Africa.

IDT partners with SOPHiA GENETICS

IDT partners with SOPHiA GENETICS | Press Release

Leading genomics solutions, combined with advanced analytics, provide benefits to hospitals and patients

BioAlps Networking Day 2019

BioAlps Networking Day 2019 Interviews

BioAlps Networking Day 2019 | Discover key speaker interviews by GGBa   The Greater Geneva Bern area (GGBa) collaborated with BioAlps once…

Neuro

NeuroRestore Center is launched

NeuroRestore Center | A new partnership to restore neurological functions through research, innovation and treatment   Defitech Foundation is partnering with…

Brain-Computer Interface

Brain-Computer Interface Technologies by Claude Clément

Brain-Computer Interface Technologies | Accelerating Neuro-Technology for Human Benefit The BioAlps team is proud to present our President’s new book….

Smart Protein

HES-SO Valais | Smart Protein Project

Smart Protein Project | In search of a meat substitute   HES-SO Valais was selected to take part in the Smart…

Positive Coating

POSITIVE COATING – 15 positive years

Fondée en 2004, POSITIVE COATING se distingue par le développement de solutions innovantes dans le domaine des traitements de surfaces basés sur les technologies PVD (Physical Vapor Deposition) et ALD (Atomic Layer Deposition), des traitements physiques et chimiques de pointe. A l’occasion de son 15-ème anniversaire, elle revient sur les grandes étapes de son parcours et donne la parole à sa direction afin qu’elle nous explique l’origine de son nom et les valeurs de l’entreprise qui ont été moteur de son succès.

microcity

Swiss serial entrepreneur joins Microcity Startup Program

Marc Thurner, founder of regenHU, Vivos Dental and mimix biotherapeutics joins Microcity as Stratup Program Manager   In October 2019,…

Entreprise Romande

Entreprise Romande – The rise of Life Sciences

The rise of Life Sciences in the past 20 years by Entreprise Romande Everything you need to know   Discover…

Agefi

Agefi – Journey to the future of healthcare professions

How will the future of healthcare professions be affected by new technologies?   Agefi’s article provides insider knowledge regarding the…

GTX Medical

GTX Medical enters the US market

“The EPFL spin-off GTX Medical moves into the US market”   The Health Valley based startup, GTX Medical, which developed…

SOPHiA GENETICS Expands it’s Executive Team

A new Chief Marketing Officer and a new Chief Information Officer have joined SOPHiA GENETICS’ Executive Team SOPHiA GENETICS, leader in…

EPFL

EPFL : The path of breast-to-brain cancer metastasis

EPFL scientists have discovered the path used by breast cancer cells to metastasize to the brain   One of the…

Fresenius Kabi

Fresenius Kabi expands biosimilar research activities in Eysins

Fresenius Kabi expands biosimilar research activities – Inauguration of state-of-the-art R&D center in Eysins, Switzerland   On 18 September 2019,…

Virdis Group

Virdis Group furthers Swiss expansion

Virdis Group announces new office opening in Lausanne, Switzerland to further Swiss expansion.

Healthcare Konnect

CureMetrix and HealthCare Konnect join forces

LA JOLLA, California, (Aug 29, 2019) – CureMetrix® a healthcare technology company that develops computer-aided detection (CAD) artificial intelligence (AI) based radiology software, announced that it entered into an agreement with HealthCare Konnect, to bring CureMetrix AI technologies to healthcare institutions in Nigeria and Algeria. The organizations will collaborate to support the clinical advancement of AI technologies to improve breast cancer detection in these regions.

University of Fribourg

Fribourg University Launches A New Master of Medicine

A new Master of Medicine was launched this autumn at Fribourg University, designed in collaboration with the Fribourg Hospital (HFR)…

Abionic

Efficiency Proof of Abionic’s Revolutionizing Sepsis Diagnosis Solution

International pivotal study successfully demonstrates Abionic’s diagnosis of sepsis within 5 minutes – 24 hours earlier compared with current standard-of-care…

EPFL

At EPFL AI fosters synergy between man and robot

EPFL scientists are using AI to improve control over robotic hand use for amputees   Artificial Intelligence (AI) is used…

HUG

Artificial Intelligence supporting HUG’s cancer treatment solutions

This year, HUG have implemented Watson for Genomics: the search engine based on tumour genetic information   Watson for Genomics…

Abionic

Abionic Signs Agreement with Genentech

Abionic and Genentech have signed an agreement to develop and provide rapid Point-of-Care tests for Asthma in the US  …

Swiss-based startup EBAMed raises CHF 1.2 Million

Funding supports development of first integrated heart motion management
system and pre-clinical testing

Drug Delivery

A glass needle gives new hope

A minuscule needle synonymous of hope for 16 million patients   FEMTOprint has developed, in partnership with the EPFL and…

ADC Therapeutics and SOPHiA GENETICS partner for biomarker discovery

ADC Therapeutics and SOPHiA GENETICS Partner in Pivotal Phase II Clinical Trial   Study to identify genomic markers associated with…

HUG

A magical healing sponge

HUG‘s Experimental Cell Therapy Lab has developed a stem cell based magical healing sponge   The bioabsorbable sponge has proven…

CHUV

Professor Solange Peters & team receive the Bonnie J. Addario 2019 prize

CHUV Professor Solange Peters & team were granted this year’s GO2 Foundation prize   This year’s Bonnie J. Addario prize…

Smart Protein

Pharma industry is boosting Swiss exports

Pharma products take first place on the Swiss export board   The high demande from international markets drives Swiss pharma…

Pryv and BGO launch privacy-centric eCRF solution

The innovative RWD eConsent solution is ideal for enhancing clinical trials with Real-World Data (RWD), achieving privacy compliance and improving patients’ engagement.

Switzerland, Morges, 12 June 2019 – Pryv, the leading Swiss provider of privacy and personal data management software, and BGO Software, a Bulgaria-based leading software services and product development company, have announced the launch of an innovative eCRF solution to manage Real-World Data (RWD) and informed electronic consent (eConsent).

UNIGE HUG

New head of UNIGE’s Faculty of Medicine and HUG’s Teaching and Research Department

Professor Cem Gabay has been appointed as the new Dean of the Faculty of Medicine (UNIGE) and Head of the…

AMAL Therapeutics acquired by Boehringer Ingelheim

Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform   Boehringer Ingelheim announced…

CSEM

A “smart bra” for detecting breast cancer

Introducing the SBRA “smart bra” project   The SBra project aims to develop an intelligent bra, equipped with sensors, capable…

Sophia Genetics

SOPHiA GENETICS welcomes Troy Cox to its Board of Directors

Troy Cox joins SOPHiA GENETICS as the company expands its decentralized approach to Data-Driven Medicine to foster a sustainable and…

UNIGE – Medicines made of solid gold

Medicines made of solid gold to help the immune system   By studying the effects of gold nanoparticles on the…

UNIGE

UNIGE – Detecting problems of the anti-bleeding system in 60 minutes

UNIGE and Franche-Comté University researchers have co-developped an innovative device enabling platelet capacity detection   This tool investigates a patient’s…

UNIGE

UNIGE : Yves Flückiger appointed as Rector for a second term

The appointment of the new rectorate of UNIGE by the Council of State was revealed on Thursday 20 June 2019.   Prof….

The Wyss Center has a new Director

Dr Mary Tolikas has been appointed as the new Director of the Wyss Center   “The Executive Board of the…

UNIGE and UNIL : “A model to decipher the complexity of gene regulation”

Scientist at the Universities of Geneva and Lausanne, Switzerland, designed a framework to analyse gene regulation, and offer a model…

Asceneuron : New member appointed to the Board of Directors

Asceneuron, an emerging leader in the development of orally bioavailable modulators of tau for the treatment of neurodegenerative diseases, today announces the appointment of Dr Eric Yuen to its Board of Directors.

The 2019 Global Startup Ecosystem Report is now available!

The Bern-Lausanne-Geneva region has been ranked #22 worldwide in this year’s edition of the Global Startup Ecosystem Report   Not only…

SICHH

The Swiss Integrative Center for Human Health (SICHH) and the Human Brain Project (HBP) unite

The SICHH and the HBP unite to further research on Alzheimer’s disease and dementia.   The SICHH welcomes the HBP…

Deep Cube – A Success Story

Watch Deep Cube‘s video and learn more about one the canton of Vaud’s striving startups!        

Back to the sources of neural diversity

By deciphering the genetic programmes of neurons of the cerebral cortex, Swiss and Belgian researchers unravel the mechanisms controlling the…

Avatarion will be present at the Digital Heath Connect

Avatarion : Robots in healthcare   The Digital Health Connect will take place on 7 June in Sierre in the…

EPFL Innovation Park

The startup as an innovative partner

Creating bridges between a large corporation and start-ups is not always an easy task. However, this becomes indispensable to ensure its capacity for innovation. For example, if one is an insurer, seeking to enhance the value of billions of medical data to help your clients stay healthy, developing partnerships with start-ups specializing in artificial intelligence is necessary. It is no longer possible to do everything internally. So how to make these bridges less slippery?

A natural barrier which prevents tumors from metastasizing

EPFL scientists have discovered a natural barrier which prevents tumors from forming new tumors or metastasizing.    Scientists from the…

SamanTree Medical

SamanTree Medical raises CHF 9.5 million

SamanTree to start commercializing its Histolog Scanner The Lausanne based startup has raised CHF 9.5 million to help launch the…

BioAlps Networking Day

Save the Date : BioAlps Networking Day 2019

The event will take place on 29 October 2019 @ Théâtre du Crochetan, Monthey (VS).   Our afternoon event will…

MindMaze

MindMaze – “Gamifying rehabilitation for stroke survivors”

Tej Tadi, founder of MindMaze, redefines stroke treatment via virtual reality   The Guardian highlights MindMaze‘s advancement in the field of…

Volumina Medical

Volumina Medical rewarded at the Startup Champions Seed Night

Volumina Medical won the Seed Night prize for its injectable implant.   The event organized by the EPFL, Venturelab and…

Sophia Genetics

A new achievement for SOPHiA GENETICS

SOPHiA GENETICS’ Solid Tumor Solution (STS) receives the CE-IVD marking   Western Switzerland based global leader in Data-Driven Medicine, SOPHiA…

EspeRare

EspeRare announces a partnership with Dermelix Biotherapeutics

EspeRare annonce un partenariat avec Dermelix Biotherapeutics pour DMX-101, et le lancement de la phase pivotale pour une thérapie in utero pour XLHED

ERC

EPFL professors awarded ERC Advanced Grants

Two EPFL professors received ERC Advanced Grants for their research in cell science and immunotherapy   Professors Pierre Gönczy and…

The Swiss Venture Capital paradigm is shifting

Is Swiss Venture Capital now rising too fast?   A few years back, Swiss pension funds remained cautious when it…

EPFL

EPFL : A new achievement towards personalized medicine

Scientists from EPFL’s BionanoPhotonic Systems (BIOS) Laboratory have created a powerful sensor which will be able to support at-home disease identification.  …

CHUV

CHUV : Prof Pantaleo’s HIV discovery recognized world wide

Prof Pantaleo’s work published as part of the “Milestones” edition of Nature.   In this edition, Nature identifies the 21…

Tech Tour Award

SOPHiA GENETICS wins the 2019 Tech Tour Growth Award

SOPHiA GENETICS was awarded the 2019 Tech Tour Growth Award out of a pool of 50 companies.   The selecting…

EPFL’S Blue Brain Project breakthrough

The EPFL’s Blue Brain Project has identified how to mathematically determine a neuron type classification based on the neuron’s shape….

An established antibiotic could help treat an aggressive form of breast cancer

UNIGE and UNIL scientists have discovered that clofazimine can be used to reduce tumors in the case of “triple negative” breast…

“Engineering cellular function without living cells”

Imitating the complexity of cellular function while having access to a simpler system which can be mathematically altered.   Scientists…

Aktiia

Aktiia changes the cuffless blood pressure measurement paradigm

Aktiia’s cuffless blood pressure measurement device only needs calibrating every two months   Aktiia’s founders have worked for the past…

Digital Health Hub

Launch of the Digital Health Hub @Biopôle

On 14 March 2019, the Digital Health Hub was launched @Biopôle   The Digital Health Hub was inaugurated today @Biopôle…

Blood Cells

Vitamin B3 analogue increases the efficiency of certain cancer treatments

Intake of Vitamin B3 analogue increases blood cell creation and in-turn positively impacts leukemia and aggressive lymphomas treatments.   Scientists…

MedCo : Medical data safely accessible

The MedCo software, developed by EPFL and CHUV researchers, grants access to medical data from different sources while respecting the…

Using Bioinformatics to Understand Genetic Diseases

The Swiss Bioinformatics Institute (SBI) and the University of Manchester have published a Practical Guide to understand “basic bioinformatics approaches…

Novostia

Neuchatel based Novostia raises CHFF 6.5 million

The funds, raised from private investors, will support Novostia in carrying out the first clinical trials.   Novostia has developed, in…

Innovaud

Scale Up Vaud: 2360 jobs worldwide in 2019

“The Scale Up Vaud initiative continues to grow and welcomes five new members.”   Innovaud shares the outcomes and statistics…

SimplicityBio

Precision for Medicine acquires SimplicityBio

The Valais based startup, SimplicityBio acquired by the USA group Precision for Medicine on 6 March 2019.   Precision for…

EPFL – The bacteria’s gait

“Bacteria walk (a bit) like we do”   Research at the EPFL’s Institute of BioEngineering and Global Health has been…

HUG

HUG breakthrough – Towards a personalized vaccine against brain cancer

The HUG, as part of the GAPVAC (Glioma Actively Personalized Vaccine Consortium) consortium financed by the European Union, have reached a…

Nanolive

Nanolive : T-cells killing cancer cells

Nanolive SA develops a high speed, high resolution and label-free live cell imaging microscope to look instantly inside living cells in…

Lunaphore

Lunaphore’s first product reaches the market

EPFL spin-off, Lunaphore released on 7 February 2019 it’s “rapid screening test for cancer”.   Lunaphore has acquired the CE…

CSEM

CSEM News : First successful osseo-neuromuscular implant

CSEM has contributed to the first dexterous and sentient hand prosthesis implant.   A female Swedish patient with hand amputation has…

Launch of the Swiss stress network

Over 30 scientists from different Swiss universities have joined the newly launched Swiss stress network.   The network enables thorough…

Lonza

Lonza to invest CHF 1 billion over 3 years in its Swiss sites

“Lonza invests 12% of its sales revenue in its plants” in Visp (VS).   Marc Funk will replace Richard Ridinger…

ChemAlive moves to the business stage

Congratulations to ChemAlive, the Lausanne (Vaud) based startup, who has just moved from its R&D to its business phase! “… The…

Alzheimer

Progressive signaling changes in the olfactory nerve of Alzheimer’s disease patients

SICHH contribue à une avancée dans la recherche des symptômes précoces de la maladie d’Alzheimer. L’équipe du Dr Alberi publie un manuscrit scientifique qui démontre pour la première fois que le nerf olfactif subit des altérations morphologiques précoces au développement de la démence.

ADC Therapeutics

ADC Therapeutics launches Phase I clinical trial

The Swiss based startup, ADC Therapeutics, has dosed a solid tumor patient in its first Phase I clinical trial.  …

EPFL and UNIL discovery : How a mutated gene can lead to different forms of cancer

“EPFL and UNIL scientists have discovered how a mutated gene can affect the three-dimensional interactions of genes in the cell,…

EPFL and ETH scientists have developed smart microrobots

Research from EPFL and ETH Zurich has lead to the development of microrobots capable of changing shape to according to…

Sophia Genetics

Sophia Genetics signs over 850 hospitals to its “data-driven medicine”

Sophia Genetics closes it Series E funding round with a $77 million cash injection. The Swiss biotech is now used…

MindMaze

MindMaze has become the first Swiss unicorn

MindMaze, spin-off of the EPFL, has developed a neurological rehabilitation system called MindMotionPRO. This system supports patients in their recovery from a…

GSK President announces his departure

GlaxoSmithKline‘s President, Philip Hampton,  has announced his departure a month after the British pharmaceutical group unveiled its plan to create…

11 EPFL Startups @ CES19 in Las Vegas

Eleven startups from EPFL were present @ CES19 this January. The event was a chance for them to showcase their…

Chemotherapy-treated tumors fight back

Researchers at EPFL have discovered that chemotherapy-treated mammary tumors create small vesicles that help them reach new organs. Read the…

Bristol-Myers Squibb to Acquire Celgene for About Billion

“The combined company will have nine products with more than billion in annual sales” Read full article in English from…

EPFL startups raised CHF 217 million in 2018

What a year for EPFL startups with a total amount raised of CHF 217 million in 2018! The investment was…

GSK and Pfizer to create a joint venture

GSK and Pfizer are joining forces to become a worldwide non-prescription drug giant.   Read AGEFI’s full article in French

“X chromosome: how genetics becomes egalitarian”

UNIGE researchers have observed how the second X chromosome in women is gradually inactivated cell by cell to avoid identical…

UNIGE

UNIGE researchers develop U-ExM: expansion microscopy

The University of Geneva researchers have developed U-ExM which delicately inflate cells to facilitate an efficient imaging of cellular ultrastructures….

HES-SO launch two personalized medicine national projects

The projects link personalized medicine and AI to offer the most efficient support at different stages of illness. Read full…

Meet Christophe Ramstein, CEO of Myotest

The Valais based startup provides personalized smart coaching software and services for runners to achieve their performance goals confidently, improve…

Using water molecules to unlock neurons’ secrets

EPFL News : “EPFL researchers have developed a method to observe the electrical activity of neurons by analyzing the behavior…

Grifols

Protéine anti-interférence pour la sécurité des transfusions sanguines chez les patients cancéreux

Medion Grifols Diagnostics finaliste du Prix Entreprise 2018/2019 du Canton de Fribourg. “Des nouveaux médicaments contre le cancer affectent les…

Industrialisé avec le soutien technologique du CSEM, SUN bioscience lance sa plateforme Gri3DTM.

Cet outil représente une première et propulse les organoïdes dans une nouvelle La culture in vitro standardisée, rapide et fiable…

Médecins, mais entrepreneurs dans l’âme

“Deux médecins, l’un au CHUV et l’autre aux HUG, développent des applications qui pourraient s’avérer révolutionnaires. Celles-ci transforment les smartphones…

BioAlps Prize 2018

We are very proud to announce the winners of the BioAlps Academy and Industry Prizes 2018. The BioAlps Award aims…

ADC Therapeutics: pemiers patients traités en Phase I/II sur ADC -602 pour le traitement de leucémie

ADC Therapeutics annonce les premiers patients traités dans le cadre de l’essai clinique de Phase I/II sur ADCT-602 dans le…

Blue Brain Project releases first-ever digital 3D brain cell atlas

“Like “going from hand-drawn maps to Google Earth,” the Blue Brain Cell Atlas allows anyone to visualize every region in…

“More than gut feeling”: Microbiota modulation technology scores at HiE 2018

“GNUBiotics (Switzerland) has won the Ingredients category in the Startup Innovation Challenge at HiE 2018 in Frankfurt. The company is…

Genève inaugure un centre de lutte contre le cancer

Le Centre de recherche translationnelle en onco-hématologie (CRTOH) a été inauguré lundi 26 novembre 2018 à Genève. Cette structure, réunissant…

EPFL partners with Standford to advance life science research

“Catalyze4Life, an Innovation Initiative of EPFL has partnered with the similar SPARK program at Stanford University to further advance its…

Caroline Heid à la tête de Microcity

Neode devenu Microcity, nomme Caroline Heid comme Présidente Lire l’interview de la nouvelle présidente

A hydrogel that adheres firmly to cartilage and meniscus

“EPFL researchers have developed a hydrogel – made up of nearly 90% water – that naturally adheres to soft tissue…

UNIGE: “Le tamoxifène peut freiner la myopathie myotubulaire”

“Des chercheurs de l’Université de Genève (UNIGE) ont identifié une molécule appelée tamoxifène, qui peut arrêter la progression de la…

Science is keeping pace with marathoners

“Thanks to sensors attached to their shoes, long-distance runners can harness the power of algorithms to analyze their stride. The…

Immunity connects gut bacteria and aging

“EPFL scientists have discovered how a dysfunction in the immune system can cause an overload of a gut bacterium. The…

AMAL Therapeutics raises 33.2 million dollars

The Geneva-based startup just announced the completion of its Series B financing round, raising in total CHF 33.2 million. Read Venturelab‘s…

World Visibility Package

BioAlps World Visibitlity Package 2019

A yearly international programme for our affiliated companies to increase their visibility. “BioAlps Bridging the World” are events giving you…

SEED Biosciences joins three talented ventures at StartLab

“Personalized medicine enabler SEED Biosciences will be the 4th start-up to join Biopôle’s StartLab, the first incubator dedicated to life…

Hidden estrogen receptors in the breast epithelium

“EPFL scientists have uncovered that next to estrogen receptor-positive and -negative cells, there are cells with very low amounts of…

Neode SA devient Microcity SA

“​Afin de soutenir la création et le développement d’entreprises innovantes et de fournir des prestations facilitant le transfert de technologie…

Chemiextra ILMAC 2018

Zusammenfassung der Veranstaltung Den ganzen Artikel lesen

1DROP Diagnostics raises 4.25 million dollars

“Investment will support commercialization and development of panels of new diagnostic tests” Read full article

Chercheuse récompensée à l’Uni de Berne

“L’Université de Berne a distingué la médecin Stephanie Ganal-Vonarburg pour ses travaux sur l’influence des microbes intestinaux de la mère…

TWIICE One exoskeleton is a step towards independence

“The new version of the TWIICE walking-assistance system is not only lighter, more comfortable and more powerful, but patients can…

Innosuisse recrute

Innosuisse recherche un/une collaborateur/collaboratrice scientifique (80-100%) pour l’équipe TST Ce poste s’insère dans la tâche passionnante d’aider à mettre en…

Andrea Ablasser wins the 2018 National Latsis Prize

The medical researcher and EPFL professor Andrea Ablasser, who studies how cells defend themselves against viral and bacterial attacks, has…

Biopôle continues expansion with new building construction

Biopôle has signed a partnership agreement with EPIC Suisse for the construction of a new building @ Epalinges. Construction of…

Breakthrough neurotechnology for treating paralysis

Three patients with chronic paraplegia were able to walk over ground thanks to precise electrical stimulation of their spinal cords…

2018 Technology by Bilan

The latest edition of Technology by Bilan magazine is out today! Great articles and insights from our HeatlhValley key players.

Andhra Pradesh MedTech Zone Limited (AMTZ)

AMTZ-The MedTech Capital of India AMTZ is creating an ecosystem for promoting medical device manufacturers, innovators and startups at Visakhapatnam,…

Innosuisse lance son programme d’impulsion “Technologies de fabrication”

Ce programme d’impulsion s’adresse à des consortiums d’entreprises et de laboratoires désireux de développer des projets d’innovation dans les domaines…

EPFL News – The “nerve-on-a-chip”

“EPFL scientists have developed a miniaturized electronic platform for the stimulation and recording of peripheral nerve fibers on a chip.”…

Switzerland Global Enterprise – Technologies Médicales. La Suisse, Terre d’Opportunités

Lire l’article complet sur le site de la Switzerland Global Enterprise. Dans le cadre de la collaboration Franco-Suisse, un déjeuner d’affaires est organisé à…

AGEFI – Endeavour Vision parmi les leaders mondiaux

Le VC genevois se spécialise dans les medtech Lire l’article complet de l’AGEFI paru le 31 août 2018.

Cendres + Métaux affiche une croissance de 8%

La société biennoise, qui à l’origine se spécialise dans le traitement des métaux précieux, augmente sa croissance grâce à la…

Fribourg – Des soutiens financiers accrus en faveur des PME désormais disponibles

Le 1er octobre, la loi révisée sur la promotion économique entre en vigueur, ainsi que son nouveau règlement adopté par…

Le Valais, Pionnier des biotechnologies ?

Lisez le blog de The Ark Foundation et visionner l’émission Eco-Logique de Canal 9 qui met en avant l’exemple du…

Addex renoue avec les bénéfices au 1er semestre

Addex est retourné au premier semestre en territoire positif au niveau du résultat net, inscrivant un bénéfice net de 2,4…

Obseva: résultats prometteurs pour le traitement linzagolix

Final results of ObsEva SA Phase 2b EDELWEISS trial of Linzagolix show sustained efficacy and Bone Mineral Density safety, for…

Alcon arrive à Genève

Alcon quitte Novartis et choisi le canton de Genève pour s’installer avec une équipe de 700 personnes. Article complet en français…

Biotech, Medtech et Pharma, un trio performant

Plusieurs acteurs de la Health Valley analyse les forces de la région de La Côte dans le domaines des sciences…

Lonza investit 400 millions de CHF à Viège (VS)

Lonza poursuit son développement en finançant la création de deux nouveaux sites dans le Canton du Valais. Article complet en français…

Addex Pharma – recoit un financement de 1,2 M£

Addex ADX10061 Receives £1.2 million Funding for Manufacture and Investigator Led Clinical Studies as part of the Tools for Human…

La convergence des technologies: Contributions aux laboratoires du futur

Article BioAlps paru dans le Magazine Chemiextra de septembre 2018, dans le cadre de l’ILMAC Lausanne.